Lisata Therapeutics, Inc. (LSTA) Net margin 2015–2024
Lisata Therapeutics, Inc. (LSTA) net profit margin by fiscal year — reported net income divided by reported revenue.
-9756.5%FY2024 · since FY2015: -92.6% → -9756.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -9756.5% | -7758.0 pp |
| FY2023 | -1998.5% | — |
| FY2015 | -92.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net incomeLSTA Gross profitLSTA Gross marginLSTA Operating incomeLSTA Operating marginLSTA Operating cash flowLSTA Free cash flowLSTA Capital expendituresLSTA Return on equityLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Total liabilitiesLSTA Shareholders’ equityLSTA overview →